(0.25%) 5 144.25 points
(0.13%) 38 491 points
(0.39%) 17 915 points
(-0.10%) $83.77
(0.52%) $1.933
(0.01%) $2 347.50
(0.44%) $27.66
(2.47%) $944.90
(-0.21%) $0.933
(-0.35%) $10.99
(-0.36%) $0.798
(1.32%) $93.08
5.15% $ 8.98
@ $8.00
Emitido: 14 feb 2024 @ 09:30
Retorno: 12.25%
Señal anterior: feb 13 - 09:30
Señal anterior:
Retorno: 4.30 %
Live Chart Being Loaded With Signals
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy...
Stats | |
---|---|
Volumen de hoy | 189 872 |
Volumen promedio | 267 917 |
Capitalización de mercado | 339.06M |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-0.570 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.860 |
ATR14 | $0.0310 (0.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-03 | Smith Ian F | Buy | 3 256 | Common Stock |
2024-04-03 | Smith Ian F | Sell | 3 256 | Restricted Stock Units |
2024-02-13 | Hanrahan Jessie | Buy | 65 000 | Employee Stock Option (Right to Buy) |
2024-02-13 | Hanrahan Jessie | Buy | 32 500 | Restricted Stock Units |
2024-02-13 | Cumbo Alexander | Buy | 240 250 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
95.48 |
Last 96 transactions |
Buy: 8 088 873 | Sell: 207 617 |
Volumen Correlación
Solid Biosciences Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
CIZN | 0.814 |
10 Correlaciones Más Negativas | |
---|---|
CATB | -0.823 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Solid Biosciences Inc Correlación - Moneda/Commodity
Solid Biosciences Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.58M (0.00 %) |
EPS: | $-4.83 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.58M (0.00 %) |
EPS: | $-4.83 |
FY | 2022 |
Ingresos: | $8.09M |
Beneficio Bruto: | $5.69M (70.25 %) |
EPS: | $-7.70 |
FY | 2021 |
Ingresos: | $13.62M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-10.14 |
Financial Reports:
No articles found.
Solid Biosciences Inc
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico